Generic SupplierYour reliable supplier of generic medications
$0.00 (0 items)Checkout

Categories list

Social bookmarks:

Our billing is certified by:

Secure shopping certificates

Special Offer!

H - Hytrin, Hyzaar, Hard On, Hard On Oral Jelly

Search by letter:

ABCDEFGHIJKLMNOPQRSTUVWXYZ
 
 
 
Hytrin $1.25
Per pill
HytrinTerazosin 1/2/5mg
Buy now!
Hyzaar $0.96
Per pill
HyzaarLosartan - Hydrochlorothiazide 50mg + 12.5mg
Buy now!
Hard On $1.70
Per pill
Hard OnSildenafil Citrate 100/120mg
Buy now!
Hard On Oral Jelly $2.50
Per pill
Hard On Oral JellySildenafil Citrate 100mg
Buy now!
 
quicksearch
quicksearch

Thank you for your mail. Yes, I received my order and everithing is fine with it. Thank you very much for the four extra pills you had, I really do appreciate it. I should recommand your site to friends and I'll come back to you soon.


Moneyback Guarantee
Subscribe to the News

Latest News

  • Applied DNA Sciences installs first pharmacy security system - Securing Pharma

    Applied DNA Sciences installs first pharmacy security systemSecuring PharmaApplied DNA Sciences has installed its smartDNA anti-intruder mist system at a pharmacy in Long Island, USA, in response to a spate of pharmacy robberies there in recent months.

  • Skepticism grows around Medco/Express Scripts deal - Reuters

    WGN RadioSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the .

  • Memo offers new account of ATF agent's NY shooting - USA TODAY

    USA TODAYMemo offers new account of ATF agent's NY shootingUSA TODAYGARDEN CITY, NJ (AP) – A document accidentally posted on a prosecutor's website cites a pharmacist's version of the friendly fire shooting death of a federal agent during a New Year's Eve robbery and differs from an account offered by an attorney for .

  • FDA approves first Cushing's syndrome drug, Corcept's Korlym - The Pharma Letter

    FDA approves first Cushing's syndrome drug, Corcept's KorlymThe Pharma LetterShares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.

  • Insurers see costs in Obama birth control rule - Chicago Tribune

    Insurers see costs in Obama birth control ruleChicago TribuneAsked what impact the requirement will have on their costs in the year to two years after it goes into effect, 40 percent of the participants said they expect the requirement will increase costs through higher pharmacy expenses.